Form 4 for LENZ LENZ Therapeutics, Inc.

Accepted 2021-07-01 00:00:00 ET · period of report 2021-04-15 · accession 0000899243-21-027014 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
DI	2021-07-01	2021-06-29	LENZ	Shah Smital	Dir	P - Purchase	$17.00	+5,882	5,882	New	+$100.0K
D	2021-07-01	2021-04-15	LENZ	Shah Smital	Dir	A - Grant	$0.00	+93.6K	93.6K	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2021-06-29	P	A	5,882	$17.00	5,882	I See footnote	—	—	(F1) These shares are held by the Martins Shah Family Trust of which the Reporting Person and her spouse are trustees. The Reporting Person disclaims beneficial ownership of such securities except to the extent of her pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of such securities for purposes of Section 16 or for any other purposes.
2	Derivative	Stock Option (right to buy)	2021-04-15	A	A	93,585	$0.00	93,585	D	$7.23 · — to 2031-04-14	93,585 Common Stock	(F2) On June 21, 2021, the Issuer completed a one-for-2.432 reverse stock split of the Issuer's Common Stock ("Reverse Stock Split"). This amount has been adjusted to give effect to this Reverse Stock Split. (F4) 1/48th of the shares subject to such option vest and become exercisable in substantially equal monthly installments on the last day of each calendar month after April 12, 2021, subject to the Reporting Person's continuous service to the Issuer on each such date. The option provides for an early exercise provision of unvested shares, subject to the Issuer's right to repurchase.